Search Within

Survivorship Research

Formats
  1. Journal Article (9006)
  2. Meeting Abstract (5248)
  3. Book Section (579)
  4. Review (367)
  5. Editorial (234)
  6. Research Letter (138)
  7. Conference Paper (104)
  8. Correspondence (92)
  9. Guidelines (90)
  10. Miscellaneous (78)
  11. Book Whole (30)
Groups
  1. Department of Medicine (9326)
  2. Population Sciences Research Program (5755)
  3. Solid Tumor Oncology Division (5245)
  4. Surgery (5201)
  5. Epidemiology and Biostatistics (3667)
  6. Division of Subspecialty Medicine (3268)

More Groups

People
  1. Clifford Hudis (905)
  2. Kenneth Offit (792)
  3. Michael Zelefsky (755)
  4. Sergio Giralt (702)
  5. Mark Robson (682)
  6. Joachim Yahalom (634)

More People

Years
  1. 2025 (386)
  2. 2024 (844)
  3. 2023 (892)
  4. 2022 (906)
  5. 2021 (922)
  6. 2020 (933)

More Years

Publications
  1. Journal of Clinical Oncology (1892)
  2. International Journal of Radiation Oncology, Biology, Physics (912)
  3. Blood (723)
  4. Annals of Surgical Oncology (603)
  5. Cancer (334)
  6. Cancer Research (333)

More Publications

Publishers
  1. Elsevier Inc. (2394)
  2. American Society of Clinical Oncology (2041)
  3. Springer (1559)
  4. Wiley Blackwell (818)
  5. Oxford University Press (792)
  6. American Society of Hematology (790)

More Publishers

Results (15966)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Report on Pediatric Brain Tumor Consortium (PBTC)-029b, a prospective phase 2 clinical trial of selumetinib in treating young patients with recurrent/progressive low-grade glioma: New results on strata 2, 5, and 6 with updated long-term survival outcomes on strata 1, 3, and 4
    Meeting Abstract

    Fangusaro, J.; Onar-Thomas, A.; Poussaint, T. Y.; Lensing, S.; Ligon, A. H.; Lindeman, N.; Banerjee, A.; Kilburn, L.; Lenzen, A.; Pillay-Smiley, N.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Phase 1 Study of the Cd40 agonistic monoclonal antibody APX005M (sotigalimab) in pediatric, adolescent, and young adult patients with recurrent or progressive CNS tumors and newly diagnosed brain stem glioma: A Pediatric Brain Tumor Consortium study (PBTC-051; NCT03389802)
    Meeting Abstract

    Lindsay, H. B.; Billups, C.; Baxter, P.; Hwang, E.; Lenzen, A.; MacDonald, T.; Pollack, I. F.; Robison, N.; Vinitsky, A.; Poussaint, T. Y.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Direct patient outreach in pediatric neurooncology to improve access to genomic profiling – The make-an-impact program
    Meeting Abstract

    Sait, S. F.; O'Donohue, T.; Hill, K.; Stockfish, E.; Giantini-Larsen, A.; Alano, T.; Bale, T.; Rosenblum, M.; Benhamida, J.; Dunkel, I.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Outcome of patients with recurrent medulloblastoma and ependymoma treated with pembrolizumab, an immune checkpoint inhibitor: A Pediatric Brain Tumor Consortium study (PBTC045)
    Meeting Abstract

    Hwang, E. I.; Kilburn, L. B.; Mitchell, D. A.; Lin, T.; Young-Poussaint, T.; Robinson, G.; Gajjar, A.; Lenzen, A.; Dorris, K.; Robison, N.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Pediatric Brain Tumor Consortium (PBTC)-056: A phase 1 study of the ADAM-10 Inhibitor, INCB007839, in children with recurrent/progressive high-grade gliomas to target microenvironmental neurologin-3
    Meeting Abstract

    Lenzen, A.; Partap, S.; Billups, C.; Poussaint, T. Y.; Sait, S. F.; Robison, N.; Castellino, C. C.; Felker, J.; Stewart, C.; Fangusaro, J.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Effects of aerobic training on determinants of peak oxygen consumption in post-treatment breast cancer
    Meeting Abstract

    Novo, R.; Michalski, M.; Stoeckel, K.; Lehman, S.; Yu, A.; Jones, L.; Eves, N.; Scott, J.
    Medicine & Science in Sports & Exercise (2024)

    Fulltext@MSK | Save
  • Minimally-invasive molecular diagnosis of diffuse leptomeningeal glioneuronal tumor (DLGNT) using cerebrospinal fluid cell-free DNA sequencing in pediatric and young adult patients
    Meeting Abstract

    Larsen, A. M. G.; Hill, K.; Hickman, R.; Bale, T. A.; Holle, B.; Mellinghoff, I.; Dunkel, I.; Souweidane, M.; Greenfield, J.; Sait, S. F.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Minimally-invasive molecular diagnosis of infiltrating brainstem gliomas through cerebrospinal fluid cell-free DNA sequencing
    Meeting Abstract

    Hill, K.; Giantini-Larsen, A.; Hickman, R. A.; Holle, B. M.; Ucpinar, B. A.; Alano, T.; Doe-Tetteh, S.; DiNapoli, S.; Riviere-Cazaux, C.; Burns, T. C.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Physical activity and cognition: Longitudinal findings from The Thinking And Living with Cancer Study
    Meeting Abstract

    Artese, A. L.; Zhou, X.; Tometich, D. B.; Small, B. J.; Ahles, T. A.; Ahn, J.; Bethea, T. N.; Breen, E. C.; Cohen, H. J.; Extermann, M.; more...
    Medicine & Science in Sports & Exercise (2024)

    Fulltext@MSK | Save
  • A phase 2 study of neoadjuvant PARP inhibition followed by radical prostatectomy (RP) in patients with unfavorable intermediate-risk or high-risk prostate cancer with BRCA1/2 gene alterations (NePtune)
    Meeting Abstract

    McKay, R. R.; Liu, L.; Pu, M.; Araneta, A.; Wang, L.; Castano, N.; Gomez, J.; Ajmera, A.; Ye, H.; Pili, R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save